5/12/2023 8:11:36 AM
Delcath Systems Sees Q1 Revenue To B About $0.6 Mln
3/29/2023 10:53:18 PM
Delcath Systems Closes Private Placement Of Up To $85 Mln
3/27/2023 8:23:55 AM
Delcath Systems Q4 Net Loss Widens To $8.5 Mln Or $0.86/shr From $5.3 Mln $0.69/shr Last Year
3/27/2023 8:19:12 AM
Delcath Systems Signs Securities Purchase Agreements For Up To $85 Mln Financing
3/27/2023 8:12:06 AM
Delcath Systems Announces FDA Acceptance Of NDA Resubmission Of Hepzato Kit With PDUFA Date Of August 14
2/16/2023 8:32:08 AM
Delcath Systems Board Votes To Appoint John Sylvester As Chairman
2/14/2023 8:53:58 AM
Delcath Systems Submits NDA Resubmission To FDA For HEPZATO Kit
1/17/2023 8:02:05 AM
Delcath Systems : Updated Results From CHOPIN Phase 1b Trial Published In Cardiovascular And Interventional Radiology
12/8/2022 8:31:35 AM
Delcath Systems Announces Private Placement Of $6.2 Mln